Header Logo

Connection

PAVAN REDDY to Female

Back to Details
This is a "connection" page, showing publications PAVAN REDDY has written about Female.
PAVAN REDDY
Connection Strength
0.725
Female
  1. Novel regulators of GVHD revealed through microbiome and metabolome patterns across distinct intestinal regions. Blood. 2025 Jun 05; 145(23):2774-2787.
    View in: PubMed
    Score: 0.036
  2. Mitochondrial complex II in intestinal epithelial cells regulates T cell-mediated immunopathology. Nat Immunol. 2021 11; 22(11):1440-1451.
    View in: PubMed
    Score: 0.028
  3. SNARE protein SEC22B regulates early embryonic development. Sci Rep. 2019 08 07; 9(1):11434.
    View in: PubMed
    Score: 0.024
  4. Host NLRP6 exacerbates graft-versus-host disease independent of gut microbial composition. Nat Microbiol. 2019 05; 4(5):800-812.
    View in: PubMed
    Score: 0.024
  5. Microbial metabolite sensor GPR43 controls severity of experimental GVHD. Nat Commun. 2018 09 10; 9(1):3674.
    View in: PubMed
    Score: 0.023
  6. a1-Antitrypsin infusion for treatment of steroid-resistant acute graft-versus-host disease. Blood. 2018 03 22; 131(12):1372-1379.
    View in: PubMed
    Score: 0.022
  7. Vorinostat plus tacrolimus/methotrexate to prevent GVHD after myeloablative conditioning, unrelated donor HCT. Blood. 2017 10 12; 130(15):1760-1767.
    View in: PubMed
    Score: 0.021
  8. Genome-Wide STAT3 Binding Analysis after Histone Deacetylase Inhibition Reveals Novel Target Genes in Dendritic Cells. J Innate Immun. 2017; 9(2):126-144.
    View in: PubMed
    Score: 0.020
  9. SAG/Rbx2-Dependent Neddylation Regulates T-Cell Responses. Am J Pathol. 2016 10; 186(10):2679-91.
    View in: PubMed
    Score: 0.020
  10. Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease. Nat Immunol. 2016 05; 17(5):505-513.
    View in: PubMed
    Score: 0.019
  11. BET bromodomain inhibition suppresses graft-versus-host disease after allogeneic bone marrow transplantation in mice. Blood. 2015 Apr 23; 125(17):2724-8.
    View in: PubMed
    Score: 0.018
  12. Histone deacetylase inhibition regulates inflammation and enhances Tregs after allogeneic hematopoietic cell transplantation in humans. Blood. 2015 Jan 29; 125(5):815-9.
    View in: PubMed
    Score: 0.018
  13. Proteasome: target for acute and chronic GVHD? Blood. 2014 Sep 04; 124(10):1551-2.
    View in: PubMed
    Score: 0.017
  14. The difficulty in diagnosing cord colitis. Biol Blood Marrow Transplant. 2014 Jul; 20(7):906-7.
    View in: PubMed
    Score: 0.017
  15. Vorinostat plus tacrolimus and mycophenolate to prevent graft-versus-host disease after related-donor reduced-intensity conditioning allogeneic haemopoietic stem-cell transplantation: a phase 1/2 trial. Lancet Oncol. 2014 Jan; 15(1):87-95.
    View in: PubMed
    Score: 0.016
  16. Allogeneic T cell responses are regulated by a specific miRNA-mRNA network. J Clin Invest. 2013 Nov; 123(11):4739-54.
    View in: PubMed
    Score: 0.016
  17. Neddylation plays an important role in the regulation of murine and human dendritic cell function. Blood. 2013 Sep 19; 122(12):2062-73.
    View in: PubMed
    Score: 0.016
  18. Host-derived CD8+ dendritic cells are required for induction of optimal graft-versus-tumor responses after experimental allogeneic bone marrow transplantation. Blood. 2013 May 16; 121(20):4231-41.
    View in: PubMed
    Score: 0.016
  19. Alpha-1-antitrypsin monotherapy reduces graft-versus-host disease after experimental allogeneic bone marrow transplantation. Proc Natl Acad Sci U S A. 2012 Jan 10; 109(2):564-9.
    View in: PubMed
    Score: 0.014
  20. Donor Tregs suppress the good with the bad after allogeneic BMT. Leuk Res. 2011 Dec; 35(12):1541-2.
    View in: PubMed
    Score: 0.014
  21. Induction of acute GVHD by sex-mismatched H-Y antigens in the absence of functional radiosensitive host hematopoietic-derived antigen-presenting cells. Blood. 2012 Apr 19; 119(16):3844-53.
    View in: PubMed
    Score: 0.014
  22. Host basophils are dispensable for induction of donor T helper 2 cell differentiation and severity of experimental graft-versus-host disease. Biol Blood Marrow Transplant. 2011 Dec; 17(12):1747-53.
    View in: PubMed
    Score: 0.014
  23. Impact of pre-existing hepatitis B infection on the outcomes of kidney transplant recipients in the United States. Clin J Am Soc Nephrol. 2011 Jun; 6(6):1481-7.
    View in: PubMed
    Score: 0.014
  24. Targeting of microRNA-142-3p in dendritic cells regulates endotoxin-induced mortality. Blood. 2011 Jun 09; 117(23):6172-83.
    View in: PubMed
    Score: 0.014
  25. Ikaros-Notch axis in host hematopoietic cells regulates experimental graft-versus-host disease. Blood. 2011 Jul 07; 118(1):192-204.
    View in: PubMed
    Score: 0.014
  26. Interleukin-6 modulates graft-versus-host responses after experimental allogeneic bone marrow transplantation. Clin Cancer Res. 2011 Jan 01; 17(1):77-88.
    View in: PubMed
    Score: 0.013
  27. Immunization with host-type CD8{alpha}+ dendritic cells reduces experimental acute GVHD in an IL-10-dependent manner. Blood. 2010 Jan 21; 115(3):724-35.
    View in: PubMed
    Score: 0.012
  28. Histone deacetylase inhibition modulates indoleamine 2,3-dioxygenase-dependent DC functions and regulates experimental graft-versus-host disease in mice. J Clin Invest. 2008 Jul; 118(7):2562-73.
    View in: PubMed
    Score: 0.011
  29. Combined Th2 cytokine deficiency in donor T cells aggravates experimental acute graft-vs-host disease. Exp Hematol. 2008 Aug; 36(8):988-96.
    View in: PubMed
    Score: 0.011
  30. Lymphopenia-induced proliferation of donor T cells reduces their capacity for causing acute graft-versus-host disease. Exp Hematol. 2007 Feb; 35(2):274-86.
    View in: PubMed
    Score: 0.010
  31. A crucial role for antigen-presenting cells and alloantigen expression in graft-versus-leukemia responses. Nat Med. 2005 Nov; 11(11):1244-9.
    View in: PubMed
    Score: 0.009
  32. Oral inflammation and microbiome dysbiosis exacerbate chronic graft-versus-host disease. Blood. 2025 Feb 20; 145(8):881-896.
    View in: PubMed
    Score: 0.009
  33. Bacteroides ovatus alleviates dysbiotic microbiota-induced graft-versus-host disease. Cell Host Microbe. 2024 Sep 11; 32(9):1621-1636.e6.
    View in: PubMed
    Score: 0.009
  34. Paradoxical effects of interleukin-18 on the severity of acute graft-versus-host disease mediated by CD4+ and CD8+ T-cell subsets after experimental allogeneic bone marrow transplantation. Blood. 2004 Nov 15; 104(10):3393-9.
    View in: PubMed
    Score: 0.009
  35. Recruitment and Retention of Hematopoietic Cell Transplantation and Cellular Therapy Physicians: A Report from the ASTCT Talent Acquisition Task Force. Transplant Cell Ther. 2024 06; 30(6):559-564.
    View in: PubMed
    Score: 0.008
  36. Histone deacetylase inhibitor suberoylanilide hydroxamic acid reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect. Proc Natl Acad Sci U S A. 2004 Mar 16; 101(11):3921-6.
    View in: PubMed
    Score: 0.008
  37. Pretreatment of donors with interleukin-18 attenuates acute graft-versus-host disease via STAT6 and preserves graft-versus-leukemia effects. Blood. 2003 Apr 01; 101(7):2877-85.
    View in: PubMed
    Score: 0.008
  38. Interleukin 18 preserves a perforin-dependent graft-versus-leukemia effect after allogeneic bone marrow transplantation. Blood. 2002 Nov 01; 100(9):3429-31.
    View in: PubMed
    Score: 0.008
  39. Colorectal cancer cells utilize autophagy to maintain mitochondrial metabolism for cell proliferation under nutrient stress. JCI Insight. 2021 06 17; 6(14).
    View in: PubMed
    Score: 0.007
  40. MicroRNA-142 Is Critical for the Homeostasis and Function of Type 1 Innate Lymphoid Cells. Immunity. 2019 09 17; 51(3):479-490.e6.
    View in: PubMed
    Score: 0.006
  41. A Phase 2 Study of Pembrolizumab during Lymphodepletion after Autologous Hematopoietic Cell Transplantation for Multiple Myeloma. Biol Blood Marrow Transplant. 2019 08; 25(8):1492-1497.
    View in: PubMed
    Score: 0.006
  42. Assessment of Individual versus Composite Endpoints of Acute Graft-versus-Host Disease in Determining Long-Term Survival after Allogeneic Transplantation. Biol Blood Marrow Transplant. 2019 08; 25(8):1682-1688.
    View in: PubMed
    Score: 0.006
  43. SAG/RBX2 E3 Ubiquitin Ligase Differentially Regulates Inflammatory Responses of Myeloid Cell Subsets. Front Immunol. 2018; 9:2882.
    View in: PubMed
    Score: 0.006
  44. Survival signal REG3a prevents crypt apoptosis to control acute gastrointestinal graft-versus-host disease. J Clin Invest. 2018 11 01; 128(11):4970-4979.
    View in: PubMed
    Score: 0.006
  45. Cognitive Function and Quality of Life in Vorinostat-Treated Patients after Matched Unrelated Donor Myeloablative Conditioning Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2019 02; 25(2):343-353.
    View in: PubMed
    Score: 0.006
  46. Altered homeostatic regulation of innate and adaptive immunity in lower gastrointestinal tract GVHD pathogenesis. J Clin Invest. 2017 Jun 30; 127(7):2441-2451.
    View in: PubMed
    Score: 0.005
  47. An early-biomarker algorithm predicts lethal graft-versus-host disease and survival. JCI Insight. 2017 02 09; 2(3):e89798.
    View in: PubMed
    Score: 0.005
  48. Infectious Risk after Allogeneic Hematopoietic Cell Transplantation Complicated by Acute Graft-versus-Host Disease. Biol Blood Marrow Transplant. 2017 Mar; 23(3):522-528.
    View in: PubMed
    Score: 0.005
  49. Combination Therapy for Graft-versus-Host Disease Prophylaxis with Etanercept and Extracorporeal Photopheresis: Results of a Phase II Clinical Trial. Biol Blood Marrow Transplant. 2016 May; 22(5):862-8.
    View in: PubMed
    Score: 0.005
  50. Reducing Treatment-Related Mortality Did Not Improve Outcomes of Allogeneic Myeloablative Hematopoietic Cell Transplantation for High-Risk Multiple Myeloma: A University of Michigan Prospective Series. Biol Blood Marrow Transplant. 2016 Jan; 22(1):54-60.
    View in: PubMed
    Score: 0.005
  51. FLT3 mutational status is an independent risk factor for adverse outcomes after allogeneic transplantation in AML. Bone Marrow Transplant. 2016 Apr; 51(4):511-520.
    View in: PubMed
    Score: 0.005
  52. Allogeneic transplantation with myeloablative FluBu4 conditioning improves survival compared to reduced intensity FluBu2 conditioning for acute myeloid leukemia in remission. Ann Hematol. 2015 Jun; 94(6):1033-41.
    View in: PubMed
    Score: 0.004
  53. Lung parenchyma-derived IL-6 promotes IL-17A-dependent acute lung injury after allogeneic stem cell transplantation. Blood. 2015 Apr 09; 125(15):2435-44.
    View in: PubMed
    Score: 0.004
  54. Participation in clinical research: perspectives of adult patients and parents of pediatric patients undergoing hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2014 Oct; 20(10):1604-11.
    View in: PubMed
    Score: 0.004
  55. Engraftment syndrome after allogeneic hematopoietic cell transplantation predicts poor outcomes. Biol Blood Marrow Transplant. 2014 Sep; 20(9):1407-17.
    View in: PubMed
    Score: 0.004
  56. Etanercept plus topical corticosteroids as initial therapy for grade one acute graft-versus-host disease after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2014 Sep; 20(9):1426-34.
    View in: PubMed
    Score: 0.004
  57. TNF-inhibition with etanercept for graft-versus-host disease prevention in high-risk HCT: lower TNFR1 levels correlate with better outcomes. Biol Blood Marrow Transplant. 2012 Oct; 18(10):1525-32.
    View in: PubMed
    Score: 0.004
  58. Plasma biomarkers of lower gastrointestinal and liver acute GVHD. Blood. 2012 Mar 22; 119(12):2960-3.
    View in: PubMed
    Score: 0.004
  59. Manipulating the bioenergetics of alloreactive T cells causes their selective apoptosis and arrests graft-versus-host disease. Sci Transl Med. 2011 Jan 26; 3(67):67ra8.
    View in: PubMed
    Score: 0.003
  60. Obesity was associated with inferior outcomes in simultaneous pancreas kidney transplant. Transplantation. 2010 May 15; 89(9):1117-25.
    View in: PubMed
    Score: 0.003
  61. Frequency of CD4(+)CD25(hi)FOXP3(+) regulatory T cells has diagnostic and prognostic value as a biomarker for acute graft-versus-host-disease. Biol Blood Marrow Transplant. 2010 Jul; 16(7):907-14.
    View in: PubMed
    Score: 0.003
  62. A biomarker panel for acute graft-versus-host disease. Blood. 2009 Jan 08; 113(2):273-8.
    View in: PubMed
    Score: 0.003
  63. Extracorporeal photopheresis reverses experimental graft-versus-host disease through regulatory T cells. Blood. 2008 Aug 15; 112(4):1515-21.
    View in: PubMed
    Score: 0.003
  64. Pilot trial on the use of etanercept and methylprednisolone as primary treatment for acute graft-versus-host disease. Biol Blood Marrow Transplant. 2005 Sep; 11(9):680-7.
    View in: PubMed
    Score: 0.002
  65. Critical role of host gammadelta T cells in experimental acute graft-versus-host disease. Blood. 2005 Jul 15; 106(2):749-55.
    View in: PubMed
    Score: 0.002
  66. Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody. Biol Blood Marrow Transplant. 2003 Aug; 9(8):505-11.
    View in: PubMed
    Score: 0.002
  67. Impaired thymic negative selection causes autoimmune graft-versus-host disease. Blood. 2003 Jul 15; 102(2):429-35.
    View in: PubMed
    Score: 0.002
  68. Early changes in gene expression profiles of hepatic GVHD uncovered by oligonucleotide microarrays. Blood. 2003 Jul 15; 102(2):763-71.
    View in: PubMed
    Score: 0.002
  69. Acute graft-versus-host disease does not require alloantigen expression on host epithelium. Nat Med. 2002 Jun; 8(6):575-81.
    View in: PubMed
    Score: 0.002
  70. Enhanced allostimulatory activity of host antigen-presenting cells in old mice intensifies acute graft-versus-host disease. J Clin Invest. 2002 May; 109(9):1249-56.
    View in: PubMed
    Score: 0.002
  71. Flt3 ligand therapy for recipients of allogeneic bone marrow transplants expands host CD8 alpha(+) dendritic cells and reduces experimental acute graft-versus-host disease. Blood. 2002 Mar 01; 99(5):1825-32.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.